Department of Human and Molecular Genetics, Institute of Molecular Medicine, Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
Department of Human and Molecular Genetics, Institute of Molecular Medicine, Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
Cell Rep. 2017 Nov 21;21(8):2147-2159. doi: 10.1016/j.celrep.2017.10.085.
As a pivotal mitotic regulator, polo-like kinase 1 (PLK1) is under highly coordinated and multi-layered regulation. However, the pathways that control PLK1's activity and function have just begun to be elucidated. PLK1 has recently been shown to be functionally modulated by post-translational modifications (PTMs), including phosphorylation and ubiquitination. Herein, we report that SUMOylation plays an essential role in regulating PLK1's mitotic function. We found that Ubc9 was recruited to PLK1 upon initial phosphorylation and activation by CDK1/cyclin B. By in vivo and in vitro SUMOylation assays, PLK1 was identified as a physiologically relevant small ubiquitin-related modifier (SUMO)-targeted protein, preferentially modified by SUMO-1. We further showed that K492 on PLK1 is essential for SUMOylation. SUMOylation causes PLK1's nuclear import and significantly increases its protein stability, both of which are critical for normal mitotic progression and genomic integrity. Our findings suggest that SUMOylation is an important regulatory mechanism governing PLK1's mitotic function.
作为一个关键的有丝分裂调节因子,丝氨酸/苏氨酸激酶 1(PLK1)受到高度协调和多层次的调节。然而,控制 PLK1 活性和功能的途径才刚刚开始被阐明。PLK1 的活性和功能可以通过翻译后修饰(PTMs)进行调节,包括磷酸化和泛素化。本文报道了 SUMO 化在调节 PLK1 的有丝分裂功能中起着重要作用。我们发现,Ubc9 在 CDK1/周期蛋白 B 的初始磷酸化和激活作用下被招募到 PLK1 上。通过体内和体外 SUMO 化实验,PLK1 被鉴定为一种生理相关的小泛素相关修饰物(SUMO)靶向蛋白,优先被 SUMO-1 修饰。我们进一步表明,PLK1 上的 K492 对于 SUMO 化是必需的。SUMO 化导致 PLK1 的核输入,并显著增加其蛋白质稳定性,这两者对于正常的有丝分裂进程和基因组完整性都是至关重要的。我们的研究结果表明,SUMO 化是调节 PLK1 有丝分裂功能的重要调节机制。